U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07422831) titled 'T2D Intermittent Nonprescription Sensors for Informed Glucose Health Tracking' on Jan. 29.
Brief Summary: The goal of this clinical trial is to learn if periodic use of over-the-counter continuous glucose monitoring (CGM) can support glucose management in people with type 2 diabetes not using insulin being treated in primary care settings. The main questions it aims to answer are:
* Is periodic use of CGM every 30 or 90 days for six months associated with reduced A1C compared to usual care at baseline?
* Is periodic use of CGM every 30 or 90 days for six months associated with increased time in range and time in tight range compar...